Genetic or pharmacological inhibition of SIRT1 abolishes NR-induced mitochondrial improvements and aggravates steatosis, and human alcoholic livers show reduced SIRT1 activity, enhanced PGC-1α acetylation, and lower NRF1/TFAM expression, mirroring these findings. This evidence concerns the gene SIRT1 and steatosis.